
Efiglin-M 1000 Tablet SR
Marketer
Medopharm
Salt Composition
Metformin (1000mg) + Teneligliptin (20mg)
Overview Efiglin-M 1000 Tablet SR
Combiflin-XR 1000mg tablets combine two active ingredients to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual-action approach helps mitigate serious diabetic complications, including renal impairment and vision loss, and may lessen the risk of cardiovascular events. Combiflin-XR 1000mg may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal therapeutic response is achieved through consistent medication adherence, coupled with a balanced diet and regular physical activity. Dosage is individualized, factoring in your health status, glycemic control, and concomitant medications. Ingesting the tablet with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under physician supervision. This medication actively supports blood sugar regulation, proactively preventing future complications. Continued adherence to your prescribed diet and exercise regimen is crucial for successful diabetes management; lifestyle choices significantly impact disease control. Commonly reported side effects encompass nausea, vomiting, diarrhea, abdominal discomfort, and cephalalgia. Hypoglycemia, a potential adverse effect, particularly when used with insulin or sulfonylureas, necessitates awareness of its symptoms and management strategies. This medication isn't universally suitable. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before initiating treatment. Potential drug interactions mandate comprehensive disclosure of all current medications to ensure patient safety. Alcohol intake should be minimized due to its potential to exacerbate hypoglycemia. Your physician will monitor renal function and blood glucose levels throughout therapy.
Primary Ingredients of Efiglin-M 1000 Tablet SR
No text provided. Please provide the text you want me to rephrase.
Uses of Efiglin-M 1000 Tablet SR
Managing type 2 diabetes
Major Benefits of Efiglin-M 1000 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Efiglin-M 1000 SR tablets should be administered with a meal.
Common Side effects of Efiglin-M 1000 Tablet SR:
- Nausea
- Vomiting
- Headache
- Hypoglycemia (low blood glucose level)
- Diarrhea
How to use Efiglin-M 1000 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Efiglin-M 1000 SR Tablets. Ingest the tablet whole; do not break, crush, or chew it. Administer this medication with food.
How Efiglin-M 1000 Tablet SR works:
Efiglin-M 1000 SR tablets contain a dual antidiabetic medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption and Efiglin-M 1000 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Efiglin-M 1000mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Efiglin-M 1000 mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability may be unaffected by Efiglin-M 1000 Tablet SR, but refrain from operating a vehicle if concentration or reaction time is impaired.
KidneyCAUTION
Patients with kidney impairment should use Efiglin-M 1000 SR tablets cautiously, potentially requiring dosage modification. Consult your physician. For those with severe kidney disease, Efiglin-M 1000 SR tablets are contraindicated. Regular monitoring of renal function is recommended during treatment.
LiverUNSAFE
Use of Efiglin-M 1000 SR tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.
What if you forget to take Efiglin-M 1000 Tablet SR :
Should you forget to take your Efiglin-M 1000 Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Efiglin-M 1000 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
